An inorganic multivalent compound (AMV404™). Mechanism of action is electro-chemical.
Non-cytotoxic at therapeutic concentrations. May be immune to microbial resistance and mutation strategies.
Eliminates microbial loads up to 6X faster than other antimicrobials.
Supports faster closure of wounds and helps reduce pain associated with infection.
Aspiera Medical is a new company with significant potential in the global wound care market. Research demonstrates the extraordinary effectiveness of our antimicrobial technology platform. We welcome discussions with companies interested in exploring product development collaborations and licensing.